Russell Investments Group, Ltd. - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 319 filers reported holding IMMUNOMEDICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$4,749,000
+1.7%
55,871
-57.6%
0.01%0.0%
Q2 2020$4,670,000
+203.8%
131,912
+15.7%
0.01%
+150.0%
Q1 2020$1,537,000
-41.1%
114,058
-7.5%
0.00%
-20.0%
Q4 2019$2,608,000
+130.4%
123,316
+44.8%
0.01%
+150.0%
Q3 2019$1,132,000
+2.2%
85,159
+9.9%
0.00%0.0%
Q4 2018$1,108,000
-40.6%
77,502
-13.4%
0.00%
-50.0%
Q3 2018$1,864,000
-11.3%
89,469
+0.8%
0.00%0.0%
Q2 2018$2,101,000
+54.5%
88,782
-4.6%
0.00%
+100.0%
Q1 2018$1,360,000
-29.1%
93,088
-20.9%
0.00%
-33.3%
Q4 2017$1,919,000
+279.2%
117,612
+105.2%
0.00%
+200.0%
Q2 2017$506,000
+32.1%
57,308
-3.2%
0.00%0.0%
Q1 2017$383,00059,2060.00%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q2 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders